Thyroid remnant ablation following administration of a diagnostic dose of iodine-131 under thyrogen stimulation.
Department of Diagnostic Radiology and Molecular Imaging, Oakland University William Beaumont School of Medicine (OUWBSM) , Beaumont Health System, Royal Oak, Michigan.
Dafang
D
Wu
Darlene
D
Fink-Bennett
Janice
J
Campbell
D002277:Carcinoma / Q000188:drug therapy / Q000517:prevention & control / Q000601:surgery; D002291:Carcinoma, Papillary; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000175:diagnosis* / Q000209:etiology; D007457:Iodine Radioisotopes / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000532:radiotherapy*; D011183:Postoperative Complications / Q000175:diagnosis* / Q000209:etiology; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000627:therapeutic use*; D000077273:Thyroid Cancer, Papillary; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects* / Q000601:surgery; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000601:surgery; D013965:Thyroidectomy / Q000009:adverse effects; D057073:Thyrotropin Alfa / Q000627:therapeutic use*; D016896:Treatment Outcome
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D057073:Thyrotropin Alfa